Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
     L04A IMMUNOSUPPRESSANTS
       L04AA Selective immunosuppressants
         L04AA02 Muromonab-CD3
         L04AA03 Antilymphocyte immunoglobulin (horse)
         L04AA04 Antithymocyte immunoglobulin (rabbit)
         L04AA06 Mycophenolic acid [DG:DG00739]
         L04AA10 Sirolimus
           D00753  Sirolimus (JAN/USAN/INN) <JP/US>
         L04AA13 Leflunomide
         L04AA15 Alefacept
         L04AA18 Everolimus
         L04AA19 Gusperimus [DG:DG00740]
         L04AA21 Efalizumab
         L04AA22 Abetimus
         L04AA23 Natalizumab
         L04AA24 Abatacept
         L04AA25 Eculizumab
         L04AA26 Belimumab
         L04AA27 Fingolimod [DG:DG00741]
         L04AA28 Belatacept
         L04AA29 Tofacitinib [DG:DG00742]
         L04AA31 Teriflunomide
         L04AA32 Apremilast
         L04AA33 Vedolizumab
         L04AA34 Alemtuzumab
         L04AA35 Begelomab
         L04AA36 Ocrelizumab
         L04AA37 Baricitinib
         L04AA38 Ozanimod [DG:DG02827]
         L04AA39 Emapalumab
         L04AA40 Cladribine
         L04AA41 Imlifidase
         L04AA42 Siponimod [DG:DG03018]
         L04AA43 Ravulizumab
         L04AA44 Upadacitinib [DG:DG02829]
         L04AA45 Filgotinib [DG:DG01991]
         L04AA46 Itacitinib [DG:DG02833]
         L04AA47 Inebilizumab
       L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
       L04AC Interleukin inhibitors
       L04AD Calcineurin inhibitors
       L04AX Other immunosuppressants
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
   S01 OPHTHALMOLOGICALS
     S01A ANTIINFECTIVES
     S01B ANTIINFLAMMATORY AGENTS
     S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
     S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
     S01F MYDRIATICS AND CYCLOPLEGICS
     S01G DECONGESTANTS AND ANTIALLERGICS
     S01H LOCAL ANESTHETICS
     S01J DIAGNOSTIC AGENTS
     S01K SURGICAL AIDS
     S01L OCULAR VASCULAR DISORDER AGENTS
     S01X OTHER OPHTHALMOLOGICALS
       S01XA Other ophthalmologicals
         S01XA01 Guaiazulen [DG:DG01149]
         S01XA02 Retinol [DG:DG00123]
         S01XA03 Sodium chloride, hypertonic
         S01XA04 Potassium iodide
         S01XA05 Sodium edetate
         S01XA06 Ethylmorphine [DG:DG01074]
         S01XA07 Alum [DG:DG01150]
         S01XA08 Acetylcysteine [DG:DG01069]
         S01XA09 Iodoheparinate
         S01XA10 Inosine [DG:DG00407]
         S01XA11 Nandrolone [DG:DG00142]
         S01XA12 Dexpanthenol
         S01XA13 Alteplase
         S01XA14 Heparin [DG:DG00150]
         S01XA15 Ascorbic acid
         S01XA18 Ciclosporin
         S01XA19 Limbal stems cells, autologous
         S01XA20 Artificial tears and other indifferent preparations
         S01XA21 Mercaptamine
         S01XA22 Ocriplasmin
         S01XA23 Sirolimus
           D00753  Sirolimus (JAN/USAN/INN) <JP/US>
         S01XA24 Cenegermin
         S01XA25 Lifitegrast [DG:DG01389]
         S01XA26 Riboflavin [DG:DG00130]
         S01XA27 Voretigene neparvovec
   S02 OTOLOGICALS
   S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: January 26, 2021
According to WHO's ATC 2021

» Japanese version